Tag: Sensyne Health

Sensyne joins GOSH for clinical AI research in childhood diseases

NNR

•

September 2, 2021

OXFORD, U.K: Sensyne Health plc has signed a five year non-exclusive Strategic Research Agreement (SRA) with Great Ormond…
Sensyne Health signs strategic research agreement with St. Luke’s University Health Network

NNR

•

May 21, 2021

DELAWARE: Sensyne Health plc (LON: SENS) has signed its first Strategic Research Agreement (SRA) in the United States…
Sensyne Health and Royal Wolverhampton sign strategic research agreement

NNR

•

January 20, 2021

OXFORD: Sensyne Health plc has signed a five year non-exclusive Strategic Research Agreement (SRA) with The Royal Wolverhampton…
Sensyne Health launches first digital health product in the U.S.

NNR

•

December 15, 2020

OXFORD: Sensyne Health plc has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S.…
Sensyne Health and Somerset NHS Foundation Trust sign strategic research agreement

NNR

•

November 16, 2020

OXFORD: Sensyne Health plc has signed a five year non-exclusive Strategic Research Agreement (SRA) with Somerset NHS Foundation…
Sensyne Health signs research collaboration agreement with Bristol Myers Squibb

NNR

•

October 23, 2020

OXFORD: Sensyne Health plc, the UK Clinical AI company, has signed a research collaboration agreement with Bristol Myers…
Sensyne Health Partners with Bayer

NNR

•

October 10, 2019

OXFORD, UK: Sensyne Health plc, the British clinical AI technology company, has joined Bayer’s LifeHub UK in an…

Stay Informed with the Latest News and Updates

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.